A study using a large electronic health record database found that patients with colour vision deficiency had lower survival rates for bladder cancer, possibly because they may not be able to detect ...
Treatment failure occurred in 46% of patients in the high-risk group vs 21% of patients in the low-risk group. Enolen is currently under investigation in a phase 1 trial to assess its safety and ...